日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification

PARP抑制剂治疗老年同源重组缺陷型新诊断晚期卵巢癌患者的疗效和毒性：剂量调整的作用

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2026.37.e9
Kim, Ji Hyun; Kim, Dongkyu Eugene; Kim, Uisuk; Bae, Jae Kyung; Jin, Wan Hu; Park, Sang-Yoon; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
PARP
毒理研究
发表日期：2026
文献求助 收藏

Correction: Proteogenomic characterization of molecular and cellular targets for treatment‑resistant subtypes in locally advanced cervical cancers

更正：局部晚期宫颈癌治疗耐药亚型分子和细胞靶点的蛋白质基因组学表征

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02522-4
Hyeon, Do Young; Nam, Dowoon; Shin, Hye-Jin; Jeong, Juhee; Jung, Eunsoo; Cho, Soo Young; Shin, Dong Hoon; Ku, Ja-Lok; Baek, Hye Jung; Yoo, Chong Woo; Hong, Eun-Kyung; Lim, Myong Cheol; Lee, Sang-Jin; Bae, Young-Ki; Kim, Jong Kwang; Bae, Jingi; Choi, Wonyoung; Kim, Su-Jin; Back, Seunghoon; Kang, Chaewon; Madar, Inamul Hasan; Kim, Hokeun; Kim, Suhwan; Kim, Duk Ki; Kang, Jihyung; Park, Geon Woo; Park, Ki Seok; Shin, Yourae; Kim, Sang Soo; Jung, Keehoon; Hwang, Daehee; Lee, Sang-Won; Kim, Joo-Young
宫颈癌
治疗耐药
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.

局部晚期宫颈癌耐药亚型分子和细胞靶点的蛋白质基因组学表征

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02256-3
Hyeon Do Young, Nam Dowoon, Shin Hye-Jin, Jeong Juhee, Jung Eunsoo, Cho Soo Young, Shin Dong Hoon, Ku Ja-Lok, Baek Hye Jung, Yoo Chong Woo, Hong Eun-Kyung, Lim Myong Cheol, Lee Sang-Jin, Bae Young-Ki, Kim Jong Kwang, Bae Jingi, Choi Wonyoung, Kim Su-Jin, Back Seunghoon, Kang Chaewon, Madar Inamul Hasan, Kim Hokeun, Kim Suhwan, Kim Duk Ki, Kang Jihyung, Park Geon Woo, Park Ki Seok, Shin Yourae, Kim Sang Soo, Jung Keehoon, Hwang Daehee, Lee Sang-Won, Kim Joo-Young
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study

化疗联合激素疗法治疗既往接受过大量治疗的晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌的疗效和安全性（ELSA/KGOG3049）：一项多中心试点研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17142320
Kim, Kidong; Choi, Chel Hun; Park, Sang-Yoon; Kim, Min Kyu; Lee, Keun Ho; Lee, Eun-Ju; Lim, Myong Cheol; Park, Young Han; Kyung, Min Sun; No, Jae Hong; Suh, Dong Hoon; Lee, Jeong-Won; Ahn, Sangjeong; Lee, Banghyun
肿瘤
免疫/内分泌
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer

BRCA突变位置与PARP抑制剂作为晚期上皮性卵巢癌一线维持治疗疗效之间的关联

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050756
Kim, Ji Hyun; Kim, Se Ik; Kim, Eun Taeg; Ha, Hyeong In; Lee, Dong-Eun; Lee, Yong Jae; Lee, Jung-Yun; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae; Park, Sang-Yoon; Lim, Myong Cheol; Nam, Eun-Ji
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Survival Outcomes Associated with the Location of BRCA Mutations in Ovarian Cancer: A Systematic Review and Meta-Analysis

卵巢癌中BRCA突变位置与生存结局相关的研究：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17101661
Kim, Ji Hyun; Yoon, Hyung Joon; Ha, Hyeong In; Kim, Eun Taeg; Kim, Dongkyu Eugene; Kim, Sangeon; Bae, Jae Kyung; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis

残余病灶对PARP抑制剂治疗晚期上皮性卵巢癌疗效的影响：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17203365
Hwang, Sekyoung; Kim, Ji Hyun; Kim, Uisuk; Ha, Hyeong In; Park, Sang-Yoon; Lim, Myong Cheol
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective Study

卵巢癌患者接受尼拉帕利治疗后出现恶心呕吐的时间趋势分析及危险因素：一项前瞻性研究

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.899
Jeong, Young Wook; Kim, Dongkyu Eugene; Kim, Ji Hyun; Kim, Se Ik; Ha, Hyeong In; Park, Sang-Yoon; Lim, Myong Cheol
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer

韩国高级别浆液性卵巢癌的整合转录组分析

期刊:PLoS Genetics
影响因子:3.7
doi:10.1371/journal.pgen.1011660
Kim, Hyondeog; Kim, Youngwook; Park, Juyeong; Shin, Dong-Min; Kim, Ji Hyun; Gunathilake, Madhawa; Kwon, So Young; Shin, Junyoung; Yoo, Chong Woo; Park, Sang-Yoon; Lim, Myong Cheol; Kim, Jeongseon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines

卵巢癌临床实践指南：韩国妇科肿瘤学会指南更新

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e69
Lee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Lee, Yoo-Young; Suh, Dong Hoon; Kim, Yong Beom
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏